Resultados de la búsqueda 71-80 of 12261 for Relaxin-2
... 2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...
2. A second purpose of this study is to obtain blood and tissue samples from participants having or at risk for developing cancer of the liver or bile ducts ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).
For cycles 2-6: patient will visit the clinic once every 2 weeks for checkups and tests. Remain in long term follow-up for a period of four additional years ...
Ir a página 22 · Ir a página 33 · Ir a página 44 · Ir a página 55 · Ir a página 66 · SiguientePróxima página. A continuación se enumeran ensayos clínicos ...
The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as ...
... II, maintenance), with some patients randomized to receive inotuzumab. Other ... II dose (RP2D of APG2575 in combination with Pomalidomide ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?